16^th International Pharmaceutical Microbiology and Biotechnology Conference May 21-22, 2018 Vienna, Austria

Prof Matin pursued his PhD in Microbiology from University of California in 1969. He worked as a lecturer, scientific officer before joining Stanford. He currently holds various academic appointments at Stanford including the department of Microbiology and Immunology.

Cancer research; biomolecualr engineering; biofilms; cellular resistance and virulence; bioremediation; stress promoters; stress sensing; systems biology; biotechnology

To be Updated soon.

Biochemistry, Molecular Biology, Biomedical Sciences

Petra Perner is the founder and director of the Institute of Computer Vision and Applied Computer Sciences in Leipzig, Germany. Under her leadership the institute developed to one of the leading institutes in basic and applied research in computer vision, data mining, machine learning, case-based reasoning and image databases. She received a diploma degree in electrical engineering in 1981 and a PhD degree in computer science in 1985. In 1989 she finished her habilitation entitled “A Methodology for the Development of Knowledge-Based Image-Interpretation Systems”. Under her guidance highly qualified national and international personnel got trained in the above mentioned high-technology fields through research projects and education programs. The tutorial on Data Mining (www.data-mining-tutorial.de) is a recognized tutorial among the domain experts and is especially designed for training industrial people on hot topics in data mining. She gave courses on Data Mining and Image Interpretation at different universities in various countries. She has been the project leader and principal investigator of various national and international research projects for which she received several research awards. Her projects are marked by the fact that they tie together high-class research with the aspect of the economic application. She is frequently invited as a guest professor for knowledge-based image inspection systems by several national and international institutes and companies. She supervised the foundation of two high-technology companies named ibai-solutions (www.ibai-solutions.de) and ImageInterpret GmbH (www.imageinterpret.de) whose teams received 4 distinct business prices for transferring image-interpretation and data-mining methods to industry. She was the principal founder and chairwoman of the Technical Committee “Machine Learning and Data Mining”. She is the chairwoman of three distinct conferences in Machine Learning, Data Mining and High-Content Analysis of Signals and Images called MLDM (www.mldm.de), ICDM (www.data-mining.forum.de) and MDA (www.mda-signals.de). Presently she is working on various medical, chemical and biomedical applications, information management applications, technical diagnosis and e-commerce applications. Most of the developments are protected by legal patent rights and can be licenced to qualified industries. She has published numerous scientific publications and patents and is frequently requested as pleanary speaker in distinct research fields as well as across disciplinces. Her vision is to build intelligent flexible and robust data-interpreting systems that are inspired by the human case-based reasoning process.

Applied Computer Science, Data Mining,

To be updated

To be updated

Ivan Kocić has completed his PhD at the age of 32 years from Medical University of Gdansk and postdoctoral studies from Tokyo Medical and Dental University, Medical Research Institute, Tokyo, Japan . He is the head of Department of Pharmacology, Medical University of Gdansk, Poland and consultant in clinical pharmacology in Pomerania region (northern Poland). . He has published more than 45 papers in reputed journals and has been serving as an editorial board member of repute.

Pharmacokinetics, Pharmacodynamics

Doctor of Biological Sciences, Professor In 1969 he graduated from Yerevan State University with major in biochemistry. The most important outcomes of the scientific results: He has developed and proposed methods for diagnosis and differential diagnosis of diseases, for hemoblastosis prognosis, diagnosis and therapy methods. "Petamcin-A" is a medicine created by him which is introduced in practical medicine. Professor P. A. Ghazaryan has published 441 scientific papers and two textbooks (Moscow), two monographs (2012, Germany). He holds a number of patents. P.A. Ghazaryan headed 26 candidate and supervised 4 doctoral theses. Since 1975 he is a member of Specialized Council 042 on Biochemistry and Molecular Biology, and since 2005 he is deputy chief editor of the scientific journal "Blood". Since 2010 he is editor-in-response of "Pharma” 'scientific-practical journal. In 2007 he became a member of the American Association of Chemists. Then he was elected a full member (academician) of the Academies of Natural Sciences of RF (2008), of the Medical and Technical Sciences of RF (2009), the European Natural Sciences (Germany, 2010). Since 2012 he is the reviewer of the American Journal of Biochemistry, the Clinical Medicine and Diagnostics, and the American Journal of Medicine and Medical Sciences.

Pharmaceutical Chemistry, Biochemistry, Molecular Biology

Dr Abbas Amini is an assistant professor at the Australian College of ACK and Western Sydney University, and the member of graduate supervisory board. After obtaining PhD, he conducted research with other Australian universities, as a postdoctoral research fellow at Monash and Deakin Universities, and as a senior research fellow at the University of Melbourne. His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group, and a recent published book in 2016. Abbas is the editor of ten reputed journals, and the committee member of 20 international conferences.

Bionanotech

Jorge is a Senior Nonclinical Toxicologist involved in Pharmacovigilance/Cosmetovigilance to support the efficacy, safety and well-use of medicines of the Company. More than 15 years of working experience in nonclinical toxicology and safety assessment in Pharma Company and Contract research Organization

Safety nonclinical evaluation, safety pharmacology, toxicokinetic and bioanalysis.